Conitec
Conitec, the National Commission for Incorporation of Technologies in the Brazilian Health System, has recently been in the news for its decision to not include liraglutide and semaglutide in Brazil's public health system, a move criticized by medical societies for exacerbating inequalities in access to obesity treatments.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Conitec is responsible for the decision not to include certain medications in the public health system.
3